Two drugs are better than one-modeling drug combinations in cancer therapy Editorial Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Immunosuppressive Agents
  • Melanoma
  • Skin Neoplasms

publication date

  • July 10, 2013

Research

keywords

  • Editorial

Identity

Digital Object Identifier (DOI)

  • 10.1126/scitranslmed.3006923

Additional Document Info

volume

  • 5

number

  • 194